242 related articles for article (PubMed ID: 33008930)
21. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT.
Park B; Kim HK; Choi YS; Kim J; Zo JI; Choi JY; Shim YM
Korean J Radiol; 2015; 16(4):929-35. PubMed ID: 26175595
[TBL] [Abstract][Full Text] [Related]
24. Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Lee H; Kim SK; Kim YI; Kim TS; Kang SH; Park WS; Yun T; Eom HS
J Nucl Med; 2014 Feb; 55(2):216-22. PubMed ID: 24365650
[TBL] [Abstract][Full Text] [Related]
25. FDG-PET/MRI with high-resolution DWI characterises the distinct phenotypes of endometrial cancer.
Tsuyoshi H; Tsujikawa T; Yamada S; Chino Y; Shinagawa A; Kurokawa T; Okazawa H; Yoshida Y
Clin Radiol; 2020 Mar; 75(3):209-215. PubMed ID: 31785782
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.
Kitajima K; Kita M; Suzuki K; Senda M; Nakamoto Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):840-5. PubMed ID: 22349717
[TBL] [Abstract][Full Text] [Related]
28. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
[TBL] [Abstract][Full Text] [Related]
29. Predictive Value of 16α-[18F]-Fluoro-17β-Estradiol PET as a Biomarker of Progestin Therapy Resistance in Patients With Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer.
Yamada S; Tsuyoshi H; Tsujikawa T; Okazawa H; Yoshida Y
Clin Nucl Med; 2019 Jul; 44(7):574-575. PubMed ID: 31107747
[TBL] [Abstract][Full Text] [Related]
30. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of tumour heterogeneity by
Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z
Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895
[TBL] [Abstract][Full Text] [Related]
32. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
[TBL] [Abstract][Full Text] [Related]
33. Clinical and prognostic value of
Albano D; Zizioli V; Odicino F; Giubbini R; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):87-93. PubMed ID: 30573388
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.
Mapelli P; Bergamini A; Fallanca F; Rancoita PMV; Cioffi R; Incerti E; Rabaiotti E; Petrone M; Mangili G; Candiani M; Gianolli L; Picchio M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):3-9. PubMed ID: 30573387
[TBL] [Abstract][Full Text] [Related]
36. A Pilot Study of Texture Analysis of Primary Tumor [
Nakajo M; Jinguji M; Shinaji T; Aoki M; Tani A; Nakabeppu Y; Nakajo M; Sato M; Yoshiura T
Mol Imaging Biol; 2019 Aug; 21(4):771-780. PubMed ID: 30397859
[TBL] [Abstract][Full Text] [Related]
37. Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
Yoshida Y; Kiyono Y; Tsujikawa T; Kurokawa T; Okazawa H; Kotsuji F
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1824-31. PubMed ID: 21656049
[TBL] [Abstract][Full Text] [Related]
38. Association of mismatch repair deficiency in endometrial cancer with
Sun X; Yao X; Zeng B; Zhu L; Shang Y; Zhang Q; He L; Jiang L
Ann Nucl Med; 2023 Dec; 37(12):655-664. PubMed ID: 37743402
[TBL] [Abstract][Full Text] [Related]
39. The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.
Walentowicz-Sadlecka M; Malkowski B; Walentowicz P; Sadlecki P; Marszalek A; Pietrzak T; Grabiec M
Biomed Res Int; 2014; 2014():234813. PubMed ID: 24719847
[TBL] [Abstract][Full Text] [Related]
40. A pilot study for texture analysis of
Nakajo M; Kajiya Y; Tani A; Jinguji M; Nakajo M; Kitazono M; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2158-2168. PubMed ID: 28770274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
